TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials September 17, 1999
TCL Archive Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds August 26, 2005